Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLARITY - Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy

NCT03221075 is registered in ClinicalTrials.gov with University Hospital of Cologne as lead sponsor.

NCT NCT03221075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03221075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLARITY - Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy
Lead sponsor
University Hospital of Cologne
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
October 25, 2022
Enrollment
203 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

invasive aspergillosis